| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2217/FCA.10.71 |
| P698 | PubMed publication ID | 20608825 |
| P2093 | author name string | Andrew H Shennan | |
| Karen Joash | |||
| Manju Chandiramani | |||
| P2860 | cites work | Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data | Q28211057 |
| Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review | Q28281326 | ||
| Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia | Q30479679 | ||
| Intrauterine growth restriction (IUGR): biometric and Doppler assessment | Q30834755 | ||
| How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview | Q30841551 | ||
| Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy | Q33200520 | ||
| Effect of Body Mass Index on pregnancy outcomes in nulliparous women delivering singleton babies | Q33291574 | ||
| Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis | Q33323271 | ||
| Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review | Q33327641 | ||
| Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity | Q33329194 | ||
| Fortnightly review: management of hypertension in pregnancy | Q33633498 | ||
| The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community | Q33930523 | ||
| Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study | Q33947553 | ||
| The epidemiology of preterm labour | Q34395056 | ||
| Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. | Q34514153 | ||
| Major congenital malformations after first-trimester exposure to ACE inhibitors | Q34535854 | ||
| Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis | Q34708320 | ||
| Eclampsia in the United Kingdom. | Q34722815 | ||
| Subclassification of preeclampsia | Q35196220 | ||
| Management of hypertension before, during, and after pregnancy | Q35583309 | ||
| A prospective study of the impact of automated dipstick urinalysis on the diagnosis of preeclampsia | Q35888426 | ||
| The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years | Q35987492 | ||
| The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months | Q36117755 | ||
| Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response | Q36738227 | ||
| Prioritisation of tests for the prediction of preeclampsia complications: a Delphi survey. | Q36799659 | ||
| Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary | Q36848278 | ||
| Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis | Q37525274 | ||
| Doppler ultrasonography in high-risk pregnancies: systematic review with meta-analysis | Q40528289 | ||
| Accuracy of inflationary versus deflationary oscillometry in pregnancy and preeclampsia: OMRON-MIT versus OMRON-M7. | Q44585081 | ||
| Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study | Q44822507 | ||
| Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. | Q46333378 | ||
| Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study | Q46337233 | ||
| Inter-arm blood pressure differences in pregnant women. | Q47390453 | ||
| The frequency and severity of placental findings in women with preeclampsia are gestational age dependent | Q47414750 | ||
| Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth | Q47853783 | ||
| Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. | Q50774079 | ||
| Rapid assessment of blood pressure in the obstetric day unit using Microlife MaM technology. | Q51019439 | ||
| Time poor: rushing decreases the accuracy and reliability of blood pressure measurement technique in pregnancy. | Q51156081 | ||
| An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A. | Q51433914 | ||
| Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy. | Q51526675 | ||
| First-trimester prediction of hypertensive disorders in pregnancy. | Q51775989 | ||
| Preeclampsia inactivates glucose-6-phosphate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells. | Q53551953 | ||
| Urinary podocyte excretion as a marker for preeclampsia. | Q53562117 | ||
| Mild gestational hypertension remote from term: progression and outcome. | Q54261580 | ||
| Accuracy assessment of the Dinamap ProCare 400 in pregnancy and preeclampsia | Q56745308 | ||
| P433 | issue | 4 | |
| P921 | main subject | decision making | Q1331926 |
| maternal health | Q6786626 | ||
| P304 | page(s) | 535-546 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Future Cardiology | Q15765184 |
| P1476 | title | Options and decision-making: hypertensive disorders of pregnancy | |
| P478 | volume | 6 |
Search more.